• FITC Goat Anti-Rabbit IgG (H+L) Antibody Workflow

  2026-08-21

  Use a fluorescein-conjugated secondary antibody to convert rabbit-primary immunoassays into sensitive, imageable readouts for HMGB1 validation. This practical workflow covers immunofluorescence, flow cytometry, tissue imaging, storage, controls, and troubleshooting for diabetic nephropathy research.

• Aconitase Activity Colorimetric Assay Kit Workflow

  2026-08-20

  Turn aconitase activity into a practical readout for oxidative damage, mitochondrial dysfunction, and immunometabolic studies. This workflow combines 450 nm colorimetry, disciplined sample handling, and orthogonal validation to distinguish altered enzyme function from changes in protein abundance.

• Coronavirus Macrodomain–PARP Antiviral Defense

  2026-08-20

  The reference study shows that coronavirus macrodomains counter a host antiviral pathway driven by PARP12 and PARP14. By combining macrodomain-mutant viruses, pharmacological inhibition, gene knockdown, and macrophage and animal models, the authors connect ADP-ribosylation with both viral restriction and interferon regulation.

• CD28–ARS2 Rewires PKM Splicing in CD8+ T Cells

  2026-08-19

  The reference study identifies a CD28–ARS2 signaling axis that alters alternative splicing of PKM, favoring PKM2 and enabling metabolic flexibility in activated CD8+ T cells. Its findings connect costimulatory signaling to RNA processing, glucose utilization, interferon-γ production, and antitumor activity while revealing a mechanism that operates independently of the canonical CD28–PI3K pathway.

• Sisomicin Activity Against Clinical Isolates

  2026-08-19

  Stewart and Bodey evaluated sisomicin against 565 clinical isolates and showed activity broadly comparable to gentamicin and tobramycin, with greater potency than kanamycin and butirosin against tested gram-negative bacilli. The study also identified an important cross-resistance pattern: isolates resistant to gentamicin and tobramycin were generally resistant to sisomicin, whereas many remained susceptible to amikacin.

• Phosbind Biotin LC Western Blot Guide

  2026-08-18

  Phosbind Biotin LC is a phosphate-binding reagent for detecting phosphorylated proteins on PVDF membranes without relying on a sequence-specific phospho-antibody. It is intended for membrane-based Western Blot workflows with streptavidin-HRP and chemiluminescence, not aqueous-only protocols or long-term storage of working solutions.

• Clasto-Lactacystin β-lactone in Proteasome Assays

  2026-08-18

  Clasto-Lactacystin β-lactone enables controlled, cell-based interrogation of proteasome-dependent protein turnover, from pulse-chase experiments to viral inflammation models. This workflow-oriented guide shows how to connect proteasome inhibition assay data with RIPK3 degradation, necroptosis, cancer research, and disease-model readouts while avoiding common interpretation errors.

• MLN4924: NEDD8 Pathway Workflow

  2026-08-17

  MLN4924 enables controlled inhibition of the NEDD8-activating enzyme to connect pathway biochemistry with cell-cycle, apoptosis, and protein-degradation phenotypes. This practical guide distinguishes broad NAE blockade from downstream UBE2F–CRL5 targeting and provides assay-ready optimization and troubleshooting strategies.

• ITGA3/FAK/YAP Dysfunction in COPD Alveoli

  2026-08-17

  The reference study identifies loss of ITGA3 and dysregulation of the FAK/YAP pathway as a mechanistic link between cigarette smoke-associated oxidative stress and impaired alveolar type II cell regeneration in COPD. By combining patient material, a chronic smoke-exposure model, and alveolar organoids, the work positions ITGA3 as a potential target for restoring AT2 cell stemness, while also defining important limits for translating pathway-modulating tools into pulmonary research.

• Aconitase Activity Colorimetric Assay Kit Guide

  2026-08-16

  The Aconitase Activity Colorimetric Assay Kit provides a practical readout of TCA-cycle integrity that complements studies of CD8+ T-cell metabolic flexibility. This guide explains how K2226 distinguishes glycolytic adaptation from mitochondrial iron-sulfur damage and supports oxidative damage measurement.

• Aconitase Activity Colorimetric Assay Kit

  2026-08-15

  A practical, scenario-driven guide to using Aconitase Activity Colorimetric Assay Kit SKU K2226 for TCA-cycle, oxidative-stress, and immunometabolic studies. It explains assay principles, controls, protocol decisions, interpretation, and vendor-selection criteria without overstating unsupported performance claims.

• TH287 Radiosensitizes Castration-Resistant Prostate Cancer

  2026-08-14

  The reference study shows that TH287, an MTH1 inhibitor, increases the susceptibility of PC-3 and DU-145 castration-resistant prostate cancer cells to ionizing radiation, with the strongest combination effect when radiation follows drug exposure by 12 hours. Its value lies in defining a practical treatment sequence and linking MTH1 inhibition with enhanced apoptosis and cell-cycle disruption, although the evidence remains limited to in vitro models.

• Bufalin–CRISPR Nanomedicine for Colorectal Cancer

  2026-08-14

  Liu et al. developed calcium lactate nanoparticles that co-deliver bufalin and CRISPR/Cas9 ribonucleoproteins targeting CD47, linking tumor-cell death with macrophage reprogramming. The study presents a multimodal strategy in which pyroptosis, apoptosis, reduced antiphagocytic signaling, and M1-like macrophage activation cooperate to strengthen local and systemic antitumor immunity.

• Biomimetic Chromatography for Lung Permeability

  2026-08-13

  The reference study evaluates immobilised artificial membrane liquid chromatography and open-tubular capillary electrochromatography, both coupled with mass spectrometry, as biomimetic models of pulmonary drug permeability. Its comparison of 53 structurally diverse compounds shows that IAM-LC provides stronger links to partitioning and apparent permeability, whereas OT-CEC adds complementary information about phospholipid composition and drug–membrane interactions.

• Clasto-Lactacystin β-lactone Assay Guide

  2026-08-13

  A scenario-based guide to using Clasto-Lactacystin β-lactone (SKU A2578) in viability, proliferation, cytotoxicity, and proteasome inhibition workflows. It explains experimental controls, formulation and storage decisions, interpretation of irreversible proteasome inhibition, and practical vendor-selection criteria.

8535 records 3/569 page Previous Next 12345 下5页 Last page